Economy/Home · Economy

Peptron Closes Limit-Down at -29.94%... Focus Turns to Whether It Can Rebound in New Trading Week on the 12th

Peptron (087010), a KOSDAQ-listed company, closed at the limit-down ahead of the Hangeul Day holiday weekend, drawing market attention to its stock price movement after trading resumes next week. ■ Limit-Down Close... Falls Sharply Below the 100,000-Won Level On the 8th, Peptron closed the session

Oseong Kwon
Staff Reporter
4 min read
Peptron Closes Limit-Down at -29.94%... Focus Turns to Whether It Can Rebound in New Trading Week on the 12th
CBC News

Peptron (087010), a KOSDAQ-listed company, closed at the limit-down ahead of the Hangeul Day holiday weekend, drawing market attention to its stock price movement after trading resumes next week.

■ Limit-Down Close... Falls Sharply Below the 100,000-Won Level On the 8th, Peptron closed the session at 91,500 won, down 39,100 won (-29.94%) from the previous trading day. The stock hit the limit-down that day, with its share price falling well below the 100,000-won level. In particular, as the decline expanded to near the daily price limit, market attention is expected to focus on the stock's future movement.

■ Market Closed on the 9th... Key Question for New Trading Week on the 12th Is 'Whether It Can Rebound' Domestic stock markets were closed on the 9th for the Hangeul Day public holiday. Accordingly, Peptron will begin trading in a new week on Monday, the 12th. The key question is whether selling pressure will continue in the new trading week or whether an attempted rebound will emerge due to the excessive decline. With short-term stock price volatility having increased, it is necessary to closely monitor changes in supply and demand and price movements after trading resumes. However, at this point, it is difficult to predict whether a rebound will occur, and the start of the first trading day after the holiday weekend is drawing attention.

■ End of Lilly SmartDepot Technology Evaluation Period Weighs on Stock Meanwhile, Peptron announced on the 7th that the technology evaluation period for the SmartDepot platform, which it had been conducting with U.S.-based Eli Lilly, had ended. This factor has since acted as a burden on the stock price.

[This article is for investment reference purposes only, and investment decisions and any resulting responsibility lie with the investor.]

Oseong Kwon
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.